UW Hospital joins national effort to study plasma treatment for COVID-19

In this photos from February, Dr. Zhou Min, a recovered COVID-19 patient who passed his 14-day quarantine, donates plasma within the city’s blood center in Wuhan in central China’s Hubei province. Plasma from recovered COVID-19 patients contains antibodies which will help reduce the viral load in patients who are fighting the disease.

W Hospital has joined the National COVID-19 Convalescent Plasma Project, which plans to review the utilization of antibodies from people that have recovered from the viral respiratory illness to treat patients newly infected with it.The project, led by doctors at Johns Hopkins University, Michigan State University and other institutions, plans to start out three studies once they’re approved by the Food and Drug Administration.

It’s not clear when approval might come, but the trials are expected to start out within weeks, not months, Dr. Nasia Safdar, medical director of infection control at UW Health, said Tuesday. The project is functioning with the American Red Cross and blood banks to urge started.

As Madison hospitals see more COVID-19 patients, they’re trying experimental treatments
LOCAL NEWS
As Madison hospitals see more COVID-19 patients, they’re trying experimental treatments
David Wahlberg | Wisconsin State Journal
The research involves using antibodies from patients who have recovered from COVID-19, or what’s referred to as convalescent plasma, which may help the immune systems of newly infected patients attack the virus. an identical approach has been used for many years for other infections like Ebola and influenza.

Leave a Reply

Your email address will not be published. Required fields are marked *